Pain Management Practice Questions

Q: The Children's Hospital Eastern Ontario Pain Scale (CHEOPS) for rating postoperative pain in children includes all components except:

Oxygen saturation. The **Children's Hospital Eastern Ontario Pain Scale (CHEOPS)** is a behavioral scale used to evaluate postoperative pain in young children (typically aged 1–7 years). It relies entirely on observable behavioral indicators rather than physiological parameters. ### Why Oxygen Saturation is the Correct Answer **Oxygen saturation** is a physiological parameter, not a behavioral one. While physiological changes (tachycardia, hypertension, or desaturation) can occur during pain, they are non-specific and can be influenced by anesthesia, respiratory distress, or anxiety. Therefore, it is **not** a component of the CHEOPS scale. ### Explanation of Incorrect Options (Components of CHEOPS) The CHEOPS scale evaluates **six** specific behavioral categories, each scored from 0–2 or 1–3: * **Cry (Option A):** Assesses the presence and intensity of crying (No cry, moaning, or vigorous scream). * **Touch (Option B):** Refers to the child’s reaction to the surgical site or wound (Not touching, reaching, or grabbing). * **Torso (Option C):** Evaluates body position and movement (Neutral, shifting, or tense/shivering). * **Other components include:** Facial expression (Smiling vs. Grimacing), Verbalization (Positive vs. Complaint), and Legs (Neutral vs. Kicking). ### High-Yield Clinical Pearls for NEET-PG * **Scoring:** The total score ranges from **4 to 13**. A score of **≥7** is generally considered indicative of significant pain requiring intervention. * **Age Group:** Most reliable in children aged **1 to 7 years**. * **Comparison:** Do not confuse CHEOPS with the **FLACC scale** (Face, Legs, Activity, Cry, Consolability), which is another common behavioral tool but uses different categories. * **Self-Reporting:** For older children (usually >4 years), the **Wong-Baker FACES Pain Rating Scale** is the preferred tool as it allows for self-reporting.

Q: Which drug is used as the first step in the WHO ladder for chronic pain management?

Aspirin. **Explanation:** The **WHO Analgesic Ladder** is a stepwise framework designed to provide adequate pain relief for patients with cancer and chronic pain. The ladder follows a sequential approach based on the intensity of the pain. **1. Why Aspirin is Correct:** The **First Step** of the ladder is for **mild pain**. It involves the use of **Non-Opioid analgesics**, which include NSAIDs (like **Aspirin**, Ibuprofen, or Diclofenac) and Paracetamol. These drugs may be used with or without "adjuvants" (e.g., antidepressants or anticonvulsants). Aspirin, being a classic NSAID, fits perfectly into this initial tier. **2. Why Other Options are Incorrect:** * **Codeine (Option C) and Dextropropoxyphene (Option D):** These are classified as **"Weak Opioids."** They represent **Step 2** of the ladder, used when mild pain persists or increases to moderate intensity. * **Morphine (Option A):** This is a **"Strong Opioid."** It represents **Step 3** of the ladder, reserved for moderate to severe pain or when Step 2 medications fail to provide relief. **3. NEET-PG High-Yield Pearls:** * **The Three Steps:** * Step 1: Non-opioids (Aspirin, Paracetamol). * Step 2: Weak opioids (Codeine, Tramadol). * Step 3: Strong opioids (Morphine, Fentanyl, Oxycodone). * **Administration Rule:** The ladder emphasizes "By the clock" (regular intervals), "By the mouth" (oral route preferred), and "By the individual" (tailored dosing). * **Adjuvants:** Can be added at **any** step of the ladder to enhance efficacy or treat specific types of pain (e.g., neuropathic pain). * **Recent Update:** Some modern versions include a **Step 4** involving interventional procedures like nerve blocks or epidurals for refractory pain.

Q: Which anatomical structure is part of the gate control theory of pain modulation?

Substantia gelatinosa. **Explanation:** The **Gate Control Theory**, proposed by Melzack and Wall in 1965, describes a mechanism in the spinal cord that modulates the transmission of pain signals to the brain. **Why Substantia Gelatinosa (SG) is correct:** The SG is located in **Lamina II of the dorsal horn** of the spinal cord. It acts as the "gate." According to the theory, stimulation of large-diameter sensory fibers (A-beta fibers, which carry touch/vibration) activates inhibitory interneurons within the SG. These interneurons release inhibitory neurotransmitters that "close the gate," preventing pain signals from small-diameter fibers (A-delta and C fibers) from reaching the second-order projection neurons (T-cells). This explains why rubbing a site of injury can alleviate pain. **Why other options are incorrect:** * **Dorsal Root Ganglion (DRG):** While the DRG contains the cell bodies of primary afferent neurons, it serves as a relay station rather than a modulatory "gate." It does not possess the inhibitory interneuron circuitry required for the gate control mechanism. * **Options C & D:** These are incorrect because the functional "gating" occurs specifically at the level of the dorsal horn (SG), not the DRG. **NEET-PG High-Yield Pearls:** * **Location:** Substantia Gelatinosa = Rexed Lamina II. * **Clinical Application:** Transcutaneous Electrical Nerve Stimulation (**TENS**) and spinal cord stimulators work on the principle of the Gate Control Theory by stimulating A-beta fibers. * **Fiber Types:** * **A-beta:** Large, myelinated (Closes the gate). * **A-delta/C:** Small, thin/unmyelinated (Opens the gate). * **Neurotransmitter:** The inhibitory interneurons in the SG often utilize **Enkephalins** or **GABA**.

Q: Which of the following opioids causes the least amount of nausea?

Alfentanil. **Explanation:** The incidence of opioid-induced nausea and vomiting (OINV) is primarily mediated by the stimulation of the **Chemoreceptor Trigger Zone (CTZ)** in the area postrema of the medulla. While all mu-opioid agonists can cause nausea, **Alfentanil** is clinically associated with the lowest incidence of emetic symptoms among the potent phenylpiperidine derivatives. **Why Alfentanil is the correct answer:** Alfentanil has a very rapid onset and a short duration of action due to its low pKa (6.5), meaning most of the drug exists in the non-ionized, lipid-soluble form at physiological pH. Studies comparing equianalgesic doses of rapid-acting opioids have consistently shown that Alfentanil triggers the CTZ less aggressively than its counterparts, making it the preferred choice when minimizing postoperative nausea is a priority. **Analysis of Incorrect Options:** * **Fentanyl:** A standard synthetic opioid used widely; however, it has a moderate to high incidence of nausea, especially when used for postoperative analgesia or as a bolus. * **Sufentanil:** 5–10 times more potent than fentanyl. Its high potency and high affinity for mu-receptors often lead to a higher incidence of nausea compared to Alfentanil. * **Remifentanil:** Despite its ultra-short duration (metabolized by plasma esterases), it is notorious for causing significant nausea and vomiting, particularly during high-dose infusions or upon emergence from anesthesia. **High-Yield Clinical Pearls for NEET-PG:** * **Potency Ratio:** Sufentanil > Fentanyl > Remifentanil > Alfentanil > Morphine. * **Context-Sensitive Half-Time:** Remifentanil is the only opioid whose context-sensitive half-time remains constant (approx. 4 mins) regardless of infusion duration. * **Drug of Choice:** Alfentanil is often preferred for short, painful procedures like **Electroconvulsive Therapy (ECT)** or retrobulbar blocks due to its rapid peak effect (1–2 mins).

Q: Which of the following is used to measure pain intensity?

Visual analog scale. The **Visual Analog Scale (VAS)** is a validated, subjective psychometric tool used to measure the intensity of pain. It typically consists of a 10 cm (100 mm) horizontal line with two anchors at the extremes: "No pain" (0) and "Worst imaginable pain" (10). Patients mark a point on the line that represents their current pain level, which is then measured in millimeters to provide a quantitative score. It is highly sensitive to changes in pain intensity and is widely used in clinical research and postoperative monitoring. **Explanation of Incorrect Options:** * **B. Visual anaesthesia score:** This is a distractor term. While there are scores to measure depth of anesthesia (like the Bispectral Index or Guedel’s stages), there is no standard "Visual Anaesthesia Score." * **C & D. Verifiable/Visual assessment of soreness:** These are fabricated terms designed to mimic the phrasing of the VAS. While "soreness" is a symptom, it is not the standardized clinical term used in validated pain assessment scales. **High-Yield Clinical Pearls for NEET-PG:** * **Unidimensional Scales:** Besides VAS, other common scales include the **Numerical Rating Scale (NRS)** (0–10) and the **Verbal Descriptor Scale (VDS)** (Mild, Moderate, Severe). * **Pediatric Pain Assessment:** The **Wong-Baker FACES Pain Rating Scale** is the gold standard for children (usually >3 years old) or patients with communication barriers. * **FLACC Scale:** Used for infants and non-verbal children (Face, Legs, Activity, Cry, Consolability). * **McGill Pain Questionnaire:** Unlike the VAS, this is a **multidimensional** tool that assesses the sensory, affective, and evaluative aspects of pain.

Q: According to the gate control theory of pain, how is pain modulated?

Substantia gelatinosa. The **Gate Control Theory**, proposed by Melzack and Wall, suggests that a "gate" mechanism in the spinal cord regulates the flow of pain impulses to the brain. ### **Why Substantia Gelatinosa is Correct** The "gate" is anatomically located in the **Substantia Gelatinosa (SG)** of the **Rexed Lamina II** in the dorsal horn of the spinal cord. * When large-diameter, myelinated **A-beta fibers** (carrying touch/vibration) are stimulated, they activate inhibitory interneurons in the SG. * These interneurons release GABA/Enkephalins, which **inhibit** the transmission of pain signals from small-diameter fibers (A-delta and C) to the T-cells (projection neurons). * Essentially, the SG acts as a modulator that "closes the gate" to pain when non-painful sensory input is present. ### **Why Other Options are Incorrect** * **A-delta fibers (Option A):** These are thin, myelinated fibers responsible for "fast pain" (sharp, localized). They tend to "open" the gate rather than modulate it. * **B fibers (Option C):** These are preganglionic autonomic fibers. They are not involved in the gate control mechanism of somatic pain. * **C fibers (Option D):** These are unmyelinated fibers responsible for "slow pain" (dull, aching). Like A-delta fibers, they carry the input that the SG modulates; they are not the site of modulation itself. ### **NEET-PG High-Yield Pearls** * **Clinical Application:** This theory is the physiological basis for **TENS (Transcutaneous Electrical Nerve Stimulation)** and why rubbing a bumped knee reduces pain. * **Fiber Order of Blockade (Local Anesthetics):** B fibers > C fibers > Small A (Delta) > Large A (Alpha/Beta). *Note: Small myelinated fibers are blocked before unmyelinated fibers.* * **Rexed Laminae:** Remember **Lamina II = Substantia Gelatinosa**. It is rich in opioid receptors (Mu and Kappa).

Q: A 57-year-old patient with severe pain due to metastatic carcinoma is managed with transdermal fentanyl. What additional medication should this patient be taking or have on hand?

Docusate. **Explanation:** **Why Docusate is Correct:** Opioid-induced constipation (OIC) is the most common and persistent side effect of long-term opioid therapy, such as transdermal fentanyl. Unlike other side effects like nausea or sedation, patients **do not develop tolerance** to the constipating effects of opioids. Opioids act on $\mu$-receptors in the gastrointestinal tract to decrease motility and secretions. Therefore, a "prophylactic bowel regimen" consisting of a stimulant laxative or a stool softener like **Docusate** is mandatory for any patient on chronic opioid therapy to prevent fecal impaction. **Analysis of Incorrect Options:** * **Apomorphine:** This is a dopamine agonist used primarily in Parkinson’s disease (rescue therapy for "off" episodes). It is not used for pain or opioid side effect management. * **Morphine:** While short-acting opioids are used for "breakthrough pain," the question asks for a medication the patient *should* be taking as a standard adjunct to the fentanyl patch. In the context of the provided options, addressing the universal side effect (constipation) takes precedence. * **Naloxone:** This is an opioid antagonist used for acute opioid overdose (respiratory depression). It is not routinely prescribed for home use unless there is a high risk of toxicity; it would also reverse the analgesic effect, causing a pain crisis. **Clinical Pearls for NEET-PG:** * **Tolerance Rule:** Patients develop tolerance to most opioid side effects (miosis and constipation are the two major exceptions). * **WHO Analgesic Ladder:** Transdermal fentanyl is a Step 3 drug (strong opioid) used for severe chronic pain. * **Fentanyl Potency:** Transdermal fentanyl is roughly 75–100 times more potent than morphine. It is contraindicated in opioid-naive patients due to the risk of fatal respiratory depression.

Q: Which of the following are methods for managing chronic pain?

All of the above. Chronic pain management utilizes a multimodal approach, ranging from pharmacological interventions to neurolytic blocks and neurosurgical procedures. **Explanation of Options:** * **Intrathecal Hyperbaric Phenol (Option A):** This is a **chemical neurolysis** technique. Phenol acts as a non-selective neurolytic agent that destroys nerve fibers. When injected intrathecally in a hyperbaric solution, it can be precisely positioned (using gravity) to target specific dorsal roots. It is primarily used for intractable cancer pain to achieve long-term analgesia. * **Anterolateral Cordotomy (Option B):** This is a **neurosurgical/ablative procedure** that involves interrupting the lateral spinothalamic tract, which carries pain and temperature sensations. It is indicated for severe, unilateral terminal cancer pain (e.g., mesothelioma) below the level of the cervical spine. * **Epidural Fentanyl (Option C):** This represents **neuraxial opioid delivery**. Fentanyl, a lipophilic opioid, acts on the mu-receptors in the substantia gelatinosa of the spinal cord. While commonly used for acute postoperative pain, tunneled epidural catheters or implanted pumps are standard for managing chronic, refractory malignant pain. **Conclusion:** Since all three methods—chemical neurolysis, surgical ablation, and neuraxial opioids—are established modalities for chronic pain, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **WHO Analgesic Ladder:** Step 1 (Non-opioids), Step 2 (Weak opioids), Step 3 (Strong opioids). Interventional techniques (like those above) are often considered "Step 4." * **Neurolysis Agents:** Alcohol (neurolytic at 50-100%, causes pain on injection) vs. Phenol (neurolytic at 5-7%, has local anesthetic properties). * **Cordotomy Target:** The spinothalamic tract is located in the anterolateral quadrant of the spinal cord. The procedure results in contralateral loss of pain and temperature.

Question 1

Which of the following statements regarding pain management in critical care is true?

Accepted Answer

Uncontrolled pain has been linked to adverse patient consequences.

Answer

It is estimated that 45% of critical care patients remember experiencing pain during their stay.

Answer

The Behaviourial Pain Scale (BPS) is composed of four observational areas and is scored from 0 to a maximum of 8.

Answer

The Critical-care Pain Observation Tool (CPOT) is not suitable for intubated patients.

Question 2

The Children's Hospital Eastern Ontario Pain Scale (CHEOPS) for rating postoperative pain in children includes all components except:

Accepted Answer

Oxygen saturation

Answer

Cry

Answer

Touch

Answer

Torso

Question 3

Which drug is used as the first step in the WHO ladder for chronic pain management?

Accepted Answer

Aspirin

Answer

Morphine

Answer

Codeine

Answer

Dextropropoxyphene

Question 4

Which anatomical structure is part of the gate control theory of pain modulation?

Accepted Answer

Substantia gelatinosa

Answer

Dorsal root ganglion

Answer

Both substantia gelatinosa and dorsal root ganglion

Answer

Neither substantia gelatinosa nor dorsal root ganglion

Question 5

Myofascial pain dysfunction may be described as:

Accepted Answer

Masticatory pain and limited function

Answer

Clicking and popping of the joint

Answer

An infectious process

Answer

Dislocation of the disc

Question 6

Which of the following opioids causes the least amount of nausea?

Accepted Answer

Alfentanil

Answer

Fentanyl

Answer

Sufentanil

Answer

Remifentanil

Question 7

Which of the following is used to measure pain intensity?

Accepted Answer

Visual analog scale

Answer

Visual anaesthesia score

Answer

Verifiable assessment of soreness

Answer

Visual assessment of soreness

Question 8

According to the gate control theory of pain, how is pain modulated?

Accepted Answer

Substantia gelatinosa

Answer

A-delta fibres

Answer

B fibres

Answer

C fibres

Question 9

A 57-year-old patient with severe pain due to metastatic carcinoma is managed with transdermal fentanyl. What additional medication should this patient be taking or have on hand?

Accepted Answer

Docusate

Answer

Apomorphine

Answer

Morphine

Answer

Naloxone

Question 10

Which of the following are methods for managing chronic pain?

Accepted Answer

All of the above

Answer

Intra-thecal hyperbaric phenol

Answer

Antrolateral cordotomy

Answer

Epidural fentanyl

Pain Management — MCQs

Pain Management — MCQs

On this page

Practice by Chapter

Want unlimited practice?